Skip to main content

Advertisement

SpringerLink
Log in

ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy – Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor–Positive Clinical Stage 2–3 Breast Cancer

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. Breast Surgical Oncology, UT MD Anderson Cancer Center, 1400 Pressler St. Unit 1434, Houston, TX, 77030, USA

    Kelly K. Hunt MD, Hannah F. Wingate PhD & Funda Meric-Bernstam MD

  2. Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA

    Vera J. Suman PhD

  3. University of Texas Southwestern Medical Center, Dallas, TX, USA

    A. Marilyn Leitch MD

  4. Doctor’s Hospital of Laredo, Laredo, TX, USA

    Gary Unzeitig MD

  5. Mayo Clinic, Rochester, MN, USA

    Judy C. Boughey MD

  6. Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, USA

    Matthew J. Ellis MB, BChir, PhD

  7. Greenebaum Cancer Center, University of Maryland, Baltimore, MD, USA

    John A. Olson MD, PhD

Authors
  1. Kelly K. Hunt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vera J. Suman PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hannah F. Wingate PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Marilyn Leitch MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gary Unzeitig MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Judy C. Boughey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Funda Meric-Bernstam MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Matthew J. Ellis MB, BChir, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. John A. Olson MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kelly K. Hunt MD.

Ethics declarations

Disclosure

Kelly K. Hunt: Consulting or advisory role for Armada Health, AstraZeneca, and Merck & Co.; research funding to MD Anderson Cancer Center from Cairn Surgical, Eli Lilly & Co, and Lumicell. Vera J. Suman: No relationships to disclose. Hannah F. Wingate: No relationships to disclose. A. Marilyn Leitch: Consulting or advisory role for Celgene, Genomic Health, and Castle Biosciences. Gary Unzeitig: No relationships to disclose. Funda Meric-Bernstam: Membership on Board of Directors or Advisory Committees (includes consulting) for Protai Bio Ltd, Astra Zeneca, Seagen (formerly Seattle Genetics), Zymeworks, OnCusp Therapeutics, Harbinger Health, Tallac Therapeutics, Daiichi Sankyo, Lengo Therapeutics, Sanofi Pharmaceuticals, FogPharma, Karyopharm, LOXO Oncology, Biovica, F. Hoffmann La-Roche. Judy C. Boughey: Consulting or advisory role for Cairn Surgical and SymBioSis; research funding to Mayo Clinic from Eli Lilly & Co. John A. Olson: Stock or other ownership in Core Prognostex. Matthew J. Ellis: Employment with AstraZeneca; patents, royalties, other intellectual property for PAM50-based diagnostics, including Prosigna (Veracyte).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hunt, K.K., Suman, V.J., Wingate, H.F. et al. ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy – Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor–Positive Clinical Stage 2–3 Breast Cancer. Ann Surg Oncol 30, 2119–2120 (2023). https://doi.org/10.1245/s10434-023-13149-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-023-13149-4

Search

Navigation